Drug intelligence / Profile preview

yiganqing rejiedu capsules

Development stage: Unknown
Lead developer: Buchang Pharmaceuticals
Administration: Oral

Overview

Yiganqing Rejiedu Capsules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is formulated as a multi-component herbal capsule indicated for the treatment of liver and hepatic diseases, including chronic hepatitis. The name reflects its therapeutic principles in TCM: 'Yigan' (benefiting the liver), 'Qingre' (clearing heat), and 'Jiedu' (detoxifying). The drug is approved for marketing in China and is part of Buchang Pharmaceutical's portfolio of TCM treatments for digestive and hepatic health. As a TCM formulation, it utilizes a combination of botanical extracts to achieve hepatoprotective and anti-inflammatory effects.

Brand names: Yiganqing Rejiedu Capsules
Other names: 益肝清热解毒胶囊Yiganqing Rejiedu Jiaonang

Beyond the preview

Go deeper on yiganqing rejiedu capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiganqing rejiedu capsules.

Explore the full profile